<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38833277</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1929-0748</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2024</Year><Month>Jun</Month><Day>04</Day></PubDate></JournalIssue><Title>JMIR research protocols</Title><ISOAbbreviation>JMIR Res Protoc</ISOAbbreviation></Journal><ArticleTitle>Incidence, Risk, and Clinical Course of New-Onset Diabetes in Long COVID: Protocol for a Systematic Review and Meta-Analysis of Cohort Studies.</ArticleTitle><Pagination><StartPage>e54853</StartPage><MedlinePgn>e54853</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e54853</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/54853</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">COVID-19, an infectious disease pandemic, affected millions of people globally, resulting in high morbidity and mortality. Causing further concern, significant proportions of COVID-19 survivors endure the lingering health effects of SARS-CoV-2, the pathogen that causes COVID-19. One of the diseases manifesting as a postacute sequela of COVID-19 (also known as "long COVID") is new-onset diabetes.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study is to examine the incidence of new-onset diabetes in patients with long COVID and assess the excess risk compared with individuals who tested negative for COVID-19. The study also aims to estimate the population-attributable fraction for COVID-19 as a risk factor for new-onset diabetes in long COVID and investigate the clinical course of new-onset diabetes cases.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a protocol for a systematic review and meta-analysis. PubMed, MEDLINE, Embase, Scopus, and Web of Science databases will be systematically searched to identify articles published between December 2019 and July 2024. A comprehensive search strategy for each database will be developed using a combination of Medical Subject Headings terms, subject headings, and text words to identify eligible studies. Cohort studies and randomized controlled trials (only control arms) involving patients with COVID-19 of any age, with follow-up data on new-onset diabetes in long COVID, will be considered for inclusion. Controls will comprise individuals who tested negative for COVID-19, with or without other respiratory tract infections. Three independent reviewers (AST, NB, and TT) will perform article selection, data extraction, and quality assessment of the studies. A fourth reviewer (ST) will review the identified studies for final inclusion in the analysis. The random-effects DerSimonian-Laird models will be used to estimate the pooled incidence proportion (%), incidence rate of diabetes (per 1000 person-years), and risk ratio (with 95% CIs) for diabetes incidence.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 1972 articles were identified through the initial search conducted in August 2023. After excluding duplicates, conducting title and abstract screening, and completing full-text reviews, 41 articles were found to be eligible for inclusion. The search will be updated in July 2024. Currently, data extraction is underway, and the meta-analysis is expected to be completed in August 2024. Publication of the study findings is anticipated by the end of 2024.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The study findings should provide valuable insights to inform both clinical practice and public health policies regarding the effective management of new-onset diabetes in patients with long COVID.</AbstractText><AbstractText Label="INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)" NlmCategory="UNASSIGNED">DERR1-10.2196/54853.</AbstractText><CopyrightInformation>&#xa9;Ananya Sri Talanki, Neha Bajaj, Twinkle Trehan, Sathish Thirunavukkarasu. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 04.06.2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Talanki</LastName><ForeName>Ananya Sri</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0009-0001-8215-8877</Identifier><AffiliationInfo><Affiliation>College of Arts and Sciences, Emory University, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Bajaj</LastName><ForeName>Neha</ForeName><Initials>N</Initials><Identifier Source="ORCID">0009-0003-5606-8653</Identifier><AffiliationInfo><Affiliation>College of Arts and Sciences, Emory University, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trehan</LastName><ForeName>Twinkle</ForeName><Initials>T</Initials><Identifier Source="ORCID">0009-0000-3857-4243</Identifier><AffiliationInfo><Affiliation>Rollins School of Public Health, Emory University, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thirunavukkarasu</LastName><ForeName>Sathish</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2016-4964</Identifier><AffiliationInfo><Affiliation>Department of Family and Preventive Medicine, Emory University School of Medicine, Atlanta, GA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Emory Global Diabetes Research Center, Woodruff Health Sciences Center, Emory University, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Res Protoc</MedlineTA><NlmUniqueID>101599504</NlmUniqueID><ISSNLinking>1929-0748</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="Y">Systematic Reviews as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="Y">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015201" MajorTopicYN="Y">Meta-Analysis as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cohort studies</Keyword><Keyword MajorTopicYN="N">incidence</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">new-onset diabetes</Keyword><Keyword MajorTopicYN="N">postacute sequela</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword><Keyword MajorTopicYN="N">type 1 diabetes</Keyword><Keyword MajorTopicYN="N">type 2 diabetes</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>4</Day><Hour>18</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>4</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>4</Day><Hour>11</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38833277</ArticleId><ArticleId IdType="pmc">PMC11185908</ArticleId><ArticleId IdType="doi">10.2196/54853</ArticleId><ArticleId IdType="pii">v13i1e54853</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>United Nations . World Economic Situation and Prospects. New York: United Nations; 2020.</Citation></Reference><Reference><Citation>WHO COVID-19 dashboard. World Health Organization.  [2024-03-26].  
 https://covid19.who.int
.</Citation></Reference><Reference><Citation>Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020;8(9):782&#x2013;792. doi: 10.1016/S2213-8587(20)30238-2. 
 
S2213-8587(20)30238-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30238-2</ArticleId><ArticleId IdType="pmc">PMC7367664</ArticleId><ArticleId IdType="pubmed">32687793</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T, Kapoor N, Cao Y, Tapp RJ, Zimmet P. Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta-analysis. Diabetes Obes Metab. 2021;23(3):870&#x2013;874. doi: 10.1111/dom.14269. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14269</ArticleId><ArticleId IdType="pmc">PMC7753574</ArticleId><ArticleId IdType="pubmed">33245182</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T, Tapp RJ, Cooper ME, Zimmet P. Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes. Diabetes Metab. 2021;47(2):101204. doi: 10.1016/j.diabet.2020.10.002. 
 
S1262-3636(20)30155-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabet.2020.10.002</ArticleId><ArticleId IdType="pmc">PMC7591867</ArticleId><ArticleId IdType="pubmed">33129968</ArticleId></ArticleIdList></Reference><Reference><Citation>GBD 2021 Diabetes Collaborators  Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203&#x2013;234. doi: 10.1016/S0140-6736(23)01301-6. 
 
S0140-6736(23)01301-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)01301-6</ArticleId><ArticleId IdType="pmc">PMC10364581</ArticleId><ArticleId IdType="pubmed">37356446</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T. Risk of mortality in COVID-19 patients with newly diagnosed and pre-existing diabetes. Prim Care Diabetes. 2022;16(1):214. doi: 10.1016/j.pcd.2021.12.002. 
 
S1751-9918(21)00218-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcd.2021.12.002</ArticleId><ArticleId IdType="pmc">PMC8695123</ArticleId><ArticleId IdType="pubmed">34974995</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T. Increased severity of COVID-19 in patients with newly diagnosed diabetes: a public health priority. Open Public Health J. 2023;16:e187494452306210. doi: 10.2174/18749445-v16-e230727-2023-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/18749445-v16-e230727-2023-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T, Cao Y, Kapoor N. Newly diagnosed diabetes in COVID-19 patients. Prim Care Diabetes. 2021;15(1):194. doi: 10.1016/j.pcd.2020.08.014. 
 
S1751-9918(20)30250-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcd.2020.08.014</ArticleId><ArticleId IdType="pmc">PMC7451214</ArticleId><ArticleId IdType="pubmed">32900656</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T, Anton MC. Newly diagnosed diabetes in patients with mild to moderate COVID-19. Diabetes Metab Syndr. 2021;15(2):569&#x2013;571. doi: 10.1016/j.dsx.2021.02.034. 
 
S1871-4021(21)00064-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.02.034</ArticleId><ArticleId IdType="pmc">PMC7925231</ArticleId><ArticleId IdType="pubmed">33706188</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee M, Pal R, Dutta S. Risk of incident diabetes post-COVID-19: a systematic review and meta-analysis. Prim Care Diabetes. 2022;16(4):591&#x2013;593. doi: 10.1016/j.pcd.2022.05.009. 
 
S1751-9918(22)00100-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcd.2022.05.009</ArticleId><ArticleId IdType="pmc">PMC9148988</ArticleId><ArticleId IdType="pubmed">35654679</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellia C, Andreadi A, D'Ippolito I, Scola L, Barraco S, Meloni M, Lauro D, Bellia A. Prevalence and risk of new-onset diabetes mellitus after COVID-19: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 2023;14:1215879. doi: 10.3389/fendo.2023.1215879. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2023.1215879</ArticleId><ArticleId IdType="pmc">PMC10507325</ArticleId><ArticleId IdType="pubmed">37732118</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding JL, Oviedo SA, Ali MK, Ofotokun I, Gander JC, Patel SA, Magliano DJ, Patzer RE. The bidirectional association between diabetes and long-COVID-19&#x2014;a systematic review. Diabetes Res Clin Pract. 2023;195:110202. doi: 10.1016/j.diabres.2022.110202. 
 
S0168-8227(22)01016-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2022.110202</ArticleId><ArticleId IdType="pmc">PMC9727969</ArticleId><ArticleId IdType="pubmed">36496030</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmati M, Yon DK, Lee SW, Udeh R, McEVoy M, Kim MS, Gyasi RM, Oh H, S&#xe1;nchez GFL, Jacob L, Li Y, Koyanagi A, Shin JI, Smith L. New-onset type 1 diabetes in children and adolescents as postacute sequelae of SARS-CoV-2 infection: a systematic review and meta-analysis of cohort studies. J Med Virol. 2023;95(6):e28833. doi: 10.1002/jmv.28833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28833</ArticleId><ArticleId IdType="pubmed">37264687</ArticleId></ArticleIdList></Reference><Reference><Citation>Ssentongo P, Zhang Y, Witmer L, Chinchilli VM, Ba DM. Association of COVID-19 with diabetes: a systematic review and meta-analysis. Sci Rep. 2022;12(1):20191. doi: 10.1038/s41598-022-24185-7. doi: 10.1038/s41598-022-24185-7.10.1038/s41598-022-24185-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-24185-7</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-24185-7</ArticleId><ArticleId IdType="pmc">PMC9684130</ArticleId><ArticleId IdType="pubmed">36418912</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T, Mei Q, Zhang Z, Walline JH, Liu Y, Zhu H, Zhang S. Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis. BMC Med. 2022;20(1):444. doi: 10.1186/s12916-022-02656-y. 
 
10.1186/s12916-022-02656-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02656-y</ArticleId><ArticleId IdType="doi">10.1186/s12916-022-02656-y</ArticleId><ArticleId IdType="pmc">PMC9666960</ArticleId><ArticleId IdType="pubmed">36380329</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T, Anton MC, Sivakumar T. New-onset diabetes in "long COVID". J Diabetes. 2021;13(8):693&#x2013;694. doi: 10.1111/1753-0407.13187. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1753-0407.13187</ArticleId><ArticleId IdType="pmc">PMC8251301</ArticleId><ArticleId IdType="pubmed">33893710</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID or post-COVID conditions. Centers for Disease Control and Prevention.  [2024-03-26].  
 https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html
.</Citation></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-Coronavirus Disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;226(9):1593&#x2013;1607. doi: 10.1093/infdis/jiac136. 
 
6569364</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Bae S, Chang HH, Kim SW. Long COVID prevalence and impact on quality of life 2&#xa0;years after acute COVID-19. Sci Rep. 2023;13(1):11207. doi: 10.1038/s41598-023-36995-4. doi: 10.1038/s41598-023-36995-4.10.1038/s41598-023-36995-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-36995-4</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-36995-4</ArticleId><ArticleId IdType="pmc">PMC10336045</ArticleId><ArticleId IdType="pubmed">37433819</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA. Cochrane Handbook for Systematic Reviews of Interventions, 2nd Edition. Chichester (UK): John Wiley &amp; Sons; 2019.</Citation></Reference><Reference><Citation>Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350:g7647. doi: 10.1136/bmj.g7647. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.g7647</ArticleId><ArticleId IdType="pubmed">25555855</ArticleId></ArticleIdList></Reference><Reference><Citation>PROSPERO: international prospective register of systematic reviews. National Institute for Health and Care Research.  [2024-03-26].  
 https://www.crd.york.ac.uk/prospero/
</Citation></Reference><Reference><Citation>Eriksen MB, Frandsen TF. The impact of Patient, Intervention, Comparison, Outcome (PICO) as a search strategy tool on literature search quality: a systematic review. J Med Libr Assoc. 2018;106(4):420&#x2013;431. doi: 10.5195/jmla.2018.345. 
 
jmla-106-420</Citation><ArticleIdList><ArticleId IdType="doi">10.5195/jmla.2018.345</ArticleId><ArticleId IdType="pmc">PMC6148624</ArticleId><ArticleId IdType="pubmed">30271283</ArticleId></ArticleIdList></Reference><Reference><Citation>International statistical classification of diseases and related health problems 10th revision. ICD-10 Version:2019. 2019.  [2024-03-26].  
 https://icd.who.int/browse10/2019/en
.</Citation></Reference><Reference><Citation>American Diabetes Association Professional Practice Committee  2. Diagnosis and classification of diabetes: standards of care in diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S20&#x2013;S42. doi: 10.2337/dc24-S002. 
 
153954</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc24-S002</ArticleId><ArticleId IdType="pmc">PMC10725812</ArticleId><ArticleId IdType="pubmed">38078589</ArticleId></ArticleIdList></Reference><Reference><Citation>Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. World Health Organization.  [2024-03-26].  
 https://tinyurl.com/4zenavte
.</Citation></Reference><Reference><Citation>WHO COVID-19 research database. World Health Organization.  [2024-03-26].  
 https://tinyurl.com/4e4f74fs
.</Citation></Reference><Reference><Citation>The world's #1 systematic review tool. Covidence.  [2024-03-26].  
 https://www.covidence.org
.</Citation></Reference><Reference><Citation>Cochrane RevMan. Cochrane Training.  [2024-03-26].  
 https://training.cochrane.org/online-learning/core-software/revman
.</Citation></Reference><Reference><Citation>Stata/SE 18.0. Stata.  [2024-03-26].  
 https://www.stata.com
.</Citation></Reference><Reference><Citation>Luchini C, Veronese N, Nottegar A, Shin JI, Gentile G, Granziol U, Soysal P, Alexinschi O, Smith L, Solmi M. Assessing the quality of studies in meta-research: review/guidelines on the most important quality assessment tools. Pharm Stat. 2021;20(1):185&#x2013;195. doi: 10.1002/pst.2068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pst.2068</ArticleId><ArticleId IdType="pubmed">32935459</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Sch&#xfc;nemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924&#x2013;926. doi: 10.1136/bmj.39489.470347.AD. 
 
336/7650/924</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Statist. 1950;21(4):607&#x2013;611. doi: 10.1214/aoms/1177729756. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1214/aoms/1177729756.full</ArticleId><ArticleId IdType="doi">10.1214/aoms/1177729756</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177&#x2013;188. doi: 10.1016/0197-2456(86)90046-2. 
 
0197-2456(86)90046-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansournia MA, Altman DG. Population attributable fraction. BMJ. 2018;360:k757. doi: 10.1136/bmj.k757. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.k757</ArticleId><ArticleId IdType="pubmed">29472187</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539&#x2013;1558. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L, Chu H. Quantifying publication bias in meta-analysis. Biometrics. 2018;74(3):785&#x2013;794. doi: 10.1111/biom.12817. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/biom.12817</ArticleId><ArticleId IdType="pmc">PMC5953768</ArticleId><ArticleId IdType="pubmed">29141096</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629&#x2013;634. doi: 10.1136/bmj.315.7109.629. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>